RIMBARLAT
This biotechnology company is developing regenerative medicines that stimulate cell regeneration in muscle tissue to treat acute muscle injuries. Their focus is on providing effective treatment options for professional athletes, enhancing recovery and performance through targeted drug therapies.
- Biotechnology
Updated 6 months ago
Funding
Raised to date
$570KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- This biotechnology company is developing regenerative medicines that stimulate cell regeneration in muscle tissue to treat acute muscle injuries. Their focus is on providing effective treatment options for professional athletes, enhancing recovery and performance through targeted drug therapies.